Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
Price: $0.91 | Change: +$0.11 | %Change: +13.75%
Volume: 336,367 | Day High/Low: 0.91/0.80 | 52 Week High/Low: 2.86/0.445
View modes: 
0 stars

Wow - Feeling better

Something is up. Thought of doubling - up a while back @ 0.50 and didnt.  Oh well.  rate and reply
0 stars

RE:What is going on?

KETZA wrote: Not even 1pm  ONCY @ 5x average volume and ONC @ twice the average volume. SP up 26% and no company news. Strange .....very strange. Another case of the little guy being the last to...read more
0 stars

RE:What is going on?

I could be wrong but it looks like a takeover is coming up.  rate and reply
0 stars

What is going on?

Not even 1pm  ONCY @ 5x average volume and ONC @ twice the average volume. SP up 26% and no company news. Strange .....very strange.  rate and reply
5 stars

Are We Entering The Final Stage?

Is this end? Will Oncolytics crash and burn? The late stage development company is risking everything on Reolysin. The market is trading ONC and ONCY as a penny stock with a market cap under $50...read more
5 stars

RE:Thoughts

The recent downturn appears to be a little over the top and has punished the company share price beyond belief. I think that the bottom is in now and should begin to gain back some of the recent...read more
4.5 stars

Thoughts

The recent trial results are depressing for those of us who had high hopes for viral oncolytic therapy. One could argue that it's "just one trial", but this was basically the best case scenario to...read more
0 stars

Seeking Alpha

http://seekingalpha.com/article/2527755-the-small-cap-high-reward-portfolio in the chance that the information regarding Reolysin isn't wrong - that Reolysin is actually a cancer-cell-killing...read more
0 stars

WOW

The risks and dangers of biotechs. Bought @ $1.50. OUCH. Another one where relying on anal-cysts can kill you.  rate and reply
0 stars

Target Prices

Targets are still encouraging.  $1.60, $2.50, $4, etc. Still some optimism out there. Can't really trust analcysts but still... "a deeper look at the data is suggestive of a positive signal...read more
0 stars

Selling

numbers aren't that high but quite a few people are packing it in with ONC. ITG sold 18,000 shares in the final minutes of trading. Not looking very positive. It's been a long 16 years. It just doesn...read more
0 stars

Quick fact about ONC

Oncolytics Biotech (NASDAQ:ONCY) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.05) earnings per share for the quarter, beating the analysts’ consensus...read more
0 stars

ONC - 4.00 PT with a "BUY" rating!!!!!!!!!!!!

http://www.wkrb13.com/markets/377671/oncolytics-biotech-pt-lowered-to-4-00-at-needham-company-llc-oncy/  rate and reply
0 stars

The sky is not falling chicken little

Oncolytics did present additional data for a subgroup of patients with a certain gene mutation known as KRAS. In this patient population, the REOLYSIN arm showed a small benefit in progression free...read more
0 stars

RE:This is why I'm in - NEW ARTICLE!!!!

BaystreetBrian wrote: http://www.proactiveinvestors.com/companies/news/56861/oncolytics-biotech-sinks-as-phase-2-study-results-miss-but-findings-still-prove-encouraging-56861.html I saw that too...read more
5 stars

This is why I'm in - NEW ARTICLE!!!!

http://www.proactiveinvestors.com/companies/news/56861/oncolytics-biotech-sinks-as-phase-2-study-results-miss-but-findings-still-prove-encouraging-56861.html  rate and reply
5 stars

RE:RE:Kaput!

Birch....we must share a mind, cuz you took my thoughts and typed them out......like you, I'm in!  rate and reply
5 stars

RE:Kaput!

LOL, they just started the next testing for Ovarian Cancer.  Some promise for sure on the last one, so, I took some today and will stick around.  Especially, because, if the news was that bad, I would...read more
1 star

Kaput!

ONC is all but finished. Get what is left of your investment now....on its way to pennies. SELL!  rate and reply
5 stars

Interesting

Someone pointed me here this morning.  Not sure why the panic with only 1% of the float dumped.  Seems like it is the end of the world or something, but not when you look at volume. GL  rate and reply

How to invest in private equity without writing a $1 million check.

Click here to watch the video